October is breast cancer awareness month, and France is all in — 61,000 diagnoses a year, a national screening push, and a Paris lab growing 'tumors on a chip' to beat the disease in four days.
October is pink in France — and this year the color comes with a countdown.
Breast cancer is still the leading cause of cancer-related death among women, and France diagnoses more than 61,000 new cases every year. That is the backdrop for Octobre rose, the month-long national awareness campaign now underway: Nice turns its landmarks pink and hosts the Pink Run & Walk on October 4, Villefranche-sur-Mer holds charity swims and marches, and the Paris Basketball Foundation dedicates its home games to the cause.
The science is moving just as fast. At the Institut Curie in Paris, researchers are growing "tumors on a chip" — miniature three-dimensional models built from a patient's own tumor cells, recreating the tumor's characteristics outside the body. Oncologists can test chemotherapy and targeted treatments on the mini-tumors instead of testing them on the patient. In trials, the chips predicted treatment sensitivity and resistance with up to 91% accuracy — in just four days.
Four days matters. The current alternative, implanting tumor samples into animal models, can take weeks to deliver results — weeks that patients with advanced, metastatic cancer often do not have. Metastatic breast cancer is especially hard to treat because tumors vary so much from one patient to another and few biomarkers exist to guide treatment choices.
This year's global theme, set by the WHO, is "Every story is unique, every journey matters" — a reminder that awareness only works when it leads somewhere: timely diagnosis, quality care, and screening that catches the disease early. From a chip in a Paris lab to a pink-lit city hall in Nice, France's October is betting that the tools are finally converging.
